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doi:10.1016/j.hkjn.2012.01.002Summary Background/Purpose: Recovery from peritoneal fibrosis (PF) involves the digestion
of accumulated collagens and remodeling. Matrix metalloproteinases (MMPs) may play an impor-
tant role in repair. The role of MMP-13, an important component in the MMP cascade, in PF is still
unclear. We examined the sequential expression of MMP synthesis during repair in a PF mouse.
Methods: Forty-eight mice at 8 weeks of age were given an intraperitoneal injection of 0.1%
chlorhexidine gluconate (CG) for 3 weeks. Control mice were injected with the same dosages
of 15% ethanol dissolved in saline. Thesemice were sacrificed, and anterior abdominal walls were
obtained on days 21, 28, 35, 42, 49, and 56. Gene expressions of MMP-2 and -13, tissue inhibition
of metalloproteinase-1 (TIMP-1) and -2, MT1-MMP, transforming growth factor-beta 1, and
collagen types I and III were analyzed by real-time polymerase chain reaction. MMP-13 enzyme
activity was also measured. In immunohistological evaluation, MMP-13 expressing cells were
examined.
Results: Thickening of the peritoneum andmarked infiltration ofmonocyteswere induced by CG,
and the alterations remained until 7 days after cessation of CG. Then tissue repair rapidly
advanced. Synthesis of collagen types I and III, MMP-2, TIMP-1 and -2, and transforming growth
factor-beta 1 in the injured peritoneum was significantly increased until day 28. These incre-
ments were preceded by an increase of MMP-13 synthesis and activity after cessation of CG. Some
infiltrating macrophages in the thickened peritoneum showed MMP-13 expression early after
cessation of CG.ephrology, Department of Internal Medicine, Juntendo University Faculty of Medicine, 2-1-1 Hongo,
o.ac.jp (Y. Tomino).
g Kong Society of Nephrology Ltd. Published by Elsevier Taiwan LLC. All rights reserved.
8 S. Aruga et al.Conclusion: MMP-13 was synthesized by infiltrating monocytes early in the repair process in the
CG-induced PF mouse. After cessation of stimulant, increase of MMP-13 synthesis may act as an
inducer of an efficient degradation cascade in collagen-rich peritoneal tissue.
背景: 腹膜纖維化的復原涉及膠原蛋白堆積的消化與其後的重塑，其中，基質金屬蛋白酶(MMPs)
在組織修復期間可能佔有重要的角色。作為MMP級聯中的重要一環，MMP-13在腹膜纖維化上的角
色仍然未明。本研究透過腹膜纖維化(PF)的小鼠，調查了在腹膜修復期間MMP生成的表現順序。
方法: 研究材料為48隻年齡8週的小鼠，先接受每天共3週的0.1%葡萄糖酸氯己定(CG)腹膜內注
射；另外對照組的注射則採用相同容量or劑量含15%乙醇的鹽水。其後陸續宰殺小鼠以取得第
21、28、35、42、49及56天的前腹壁檢體，並採用實時PCR測量以下的基因表現：MMP-2-13、
TIMP-1-2、MT1-MMP、TGF-b(1)、及I III型膠原蛋白。此外亦同時測量MMP-13之酵素活動，並對
表現MMP-13的細胞作免疫組織學評估。
結果: 在CG誘導下，可見腹膜增厚及單核球的明顯浸潤，直至停止CG後7天，其後可見組織修復
的快速進行。在停止CG後的受損腹膜中，首先可見MMP-13生成與活動的增加，其後亦可見I III型
膠原蛋白、MMP-2、TIMP-1-2、及TGF-b(1)生成的明顯增加，直至第28天。在停止CG後的早期，
可見增厚腹膜中有若干巨噬細胞具MMP-13表現。
結論: 在CG所致的PF小鼠中，腹膜修復早期已可見浸潤的單核球產生MMP-13。在停止刺激後，在
富含膠原蛋白的腹膜環境中，MMP-13似乎可促使一個高效降解級聯的進行。Introduction
Marked thickening of the peritoneum and vasculopathy in
the submesothelial compact zone (SMC) were reported in
long-term peritoneal dialysis (PD) patients.1 The key
factors of peritoneal regeneration after cessation of PD are
still unclear. Recovery from peritoneal fibrosis (PF) to
a normal peritoneum involved the destruction of accumu-
lated collagens and excess matrix and tissue remodeling in
the peritoneum. Matrix metalloproteinases (MMPs) may
play important roles in such events.
Elevated expression of collagen type III was observed in
early or active lesions of pulmonary fibrosis, and expression
of collagen type I increased in chronic pulmonary fibrosis.2
In scar formation in the healing process of full-thickness
excisional wounds, the synthesis of collagen types I and III
increased during the later phase of wound healing and
peaked at around 2 weeks after surgery.3 Suga et al4 and
Fukuda et al5 reported that idiopathic pulmonary fibrosis
cases showed a predominant expression of MMP-9, whereas
nonspecific interstitial pneumonia and bronchiolitis oblit-
erans organizing pneumonia cases showed a predominant
MMP-2 expression in bronchoalveolar lavage fluid and in
tissues. MMP-1 and -9 expressions were elevated during
granulation tissue formation and re-epithelialization,
whereas in the remodeling phase, MMP-2 and MMP-9
messenger RNAs (mRNAs) were increased in experimental
full-thickness wound healing.3 Collagenases MMP-1, -8 and-
13 can cleave collagens into specific fragments for an effi-
cient degradation by gelatinase,6 and MMP-13 especially
can activate latent transforming growth factor-beta 1 (TGF-
b1) on cell surfaces.7 Once TGF-b1 has been activated, it
increases collagen synthesis,8,9 tissue inhibition of
metalloproteinase-1 (TIMP-1),10 and MMP-2 activity through
the inhibition of TIMP-2.11 Furthermore, TGF-b1 can
suppress expression of collagenase.12 Since these proteo-
lytic activities are regulated by several mechanisms
including regulation of gene expression by cytokines or
hormones, and extracellular cleavage of the proenzyme to
the active form by membrane-type MMP (MT-MMP)inhibition by TIMPs, the qualitative pattern and quantita-
tive levels of MMPs vary among tissues, diseases, tumors,
inflammatory conditions, and cell lines.13
The objective of the present study was to find a clue on
how to break out of the vicious cycle in long-term PD
patients with severe PF. In this study, we observed serial
and temporal alterations of collagens, MMPs and TIMPs and
TGF-b1, associated with tissue fibrosis and remodeling in
the process of peritoneal repair after repeated intraperi-
toneal injection of chlorhexidine gluconate (CG) in mice.
We examined the relationship between these alterations
and morphological findings in peritoneal repair.
Materials and methods
Animal model
Fifty-one C57BL/6 male mice were purchased at 8 weeks of
age from CLEA Japan Inc. (Tokyo, Japan). They were
housed in a specific pathogen free (SPF), light- and
temperature-controlled room. They had free access to
laboratory chow and tap water in standard rodent cages. All
animal studies were performed according to the guidelines
of the Ethics Review Committee for Animal Experimenta-
tion of Juntendo University Faculty of Medicine. Forty-eight
mice were given an intraperitoneal injection (i.p.) of
0.35 mL of 0.1% CG and 15% ethanol dissolved in saline
three times a week for 3 weeks.14 The mice were injected
with the same dosages of 15% ethanol dissolved in saline
without CG as control (nZ 3). These mice were sacrificed,
and the anterior abdominal walls were collected on days
21, 28, 35, 42, 49, and 56 (nZ 8 in each day).
Histological assessment
Serial morphological changes in the peritoneum after
repeated CG injection were evaluated. The parietal
abdominal walls were fixed in 10% neutral-buffered form-
aldehyde and embedded in paraffin. Then 4-mm sections
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Thickening of the SMC, an area from the surface of the
abdominal muscle to the peritoneal cavity, was defined as
interstitial fibrosis.14 We quantified the thickness of SMC
from five areas in each of the five figures (a total of 25
points/mouse). Quantification of SMC thickness was per-
formed by image analysis. The images were analyzed using
the Release 3.0 KS400 Imaging System, (Carl Zeiss, Ober-
kocken, Germany).
Quantitative mRNA analyses by real-time PCR
The parietal abdominal walls were dissected and snap-
frozen in liquid nitrogen for total RNA extraction. RNA was
extracted with Trizol (RNeasy Mini Kit; Qiagen, Tokyo,
Japan). Complementary DNA was synthesized using random
hexamers (Quantum RNA kit; Ambion, Austin, TX, USA) and
SuperScript II RNase H Reverse Transcriptase (Life Tech-
nologies, Rockville, MD, USA). Primers and fluorogenic
probes of collagen types I and III, MMP-13 and -2, TIMP-1
and -2, and TGF-b1 were obtained from a commercial base
(Taqman Gene Expression Assays; Applied Biosystems,
Foster City, CA, USA). The assay IDs were collagen type I;
Mm00801666-g1, collagen type III; Mm00802331-m1, MMP-
13; Mm01168713-m1, MMP-2; Mm00439498-m1, TIMP-1;
Mm00441818-m1, TIMP-2; Mm00441825-m1 and TGF-b1;
Mm03024053-m1. The complementary DNA obtained was
further amplified by a real-time polymerase chain reaction
(PCR) system (ABI prism 7500 Real-Time PCR System;
Perkin-Elmer, Foster City, CA, USA). Initial template
concentration was derived from the cycle number at which
the fluorescent signals cross the threshold in the exponen-
tial phase of the PCR reaction. Relative gene expression
was determined based on the threshold cycles (Ct values).
The PCR parameters were 95C for 10 minutes, followed by
50 cycles at 95C for 15 seconds and 60C for 60 seconds.
MMP-13 enzyme activity
MMP-13 (mouse interstitial collagenase) activity was
detected on days 21, 28, 35, 42, 49, and 56 using an
Enzolyte 520 MMP-13 assay kit (Anaspec, San Jose, CA,
USA). Mouse peritoneal tissue samples from each group
(nZ 4) were homogenized in assay buffer and then
centrifuged at 13,500 rpm at room temperature for 15
minutes. Supernatant was collected and stored at e80C
until use. The activity assay was performed according to
the manufacturer’s instructions using 5-FAM/QXL520 FRET
peptide (Anaspec) as the substrate. Fluorescence on
cleavage was monitored at excitation/emission wave-
lengths of 490/520 nm, and the results were expressed as
relative fluorescent units. This phase of the experiment was
repeated twice.
Immunohistochemistry
Peritoneal tissues were stained for F4/80 and MMP-13.
Using the same 4-mm sections, immunohistochemical anal-
yses were performed. All sections were deparaffinized in
xylene, followed by 100% ethanol, and then placed in
freshly prepared methanol/0.3% H2O2 solution for 15minutes to block endogenous peroxidase activity. Micro-
wave antigen retrieval was performed with hot 0.01 mol/
L-citrate buffer for 12 minutes. The sections were returned
to room temperature before subsequent procedures were
performed, and then blocked with blocking solution con-
taining 2% bovine serum albumin, 2% fetal calf serum, and
0.2% fish gelatin in 0.01 mol/L phosphate buffered saline
(PBS; pH 7.4) for 30 minutes, followed by overnight incu-
bation with rat anti-mouse F4/80 antibody diluted 1:100
(AbD Serotec, Oxford, UK) and sheep anti-human MMP-13
antibody diluted 1:200 (AbD Serotec) at 4C. The sections
for F4/80 were incubated with goat anti-rat IgG, which was
conjugated to peroxidase-labeled polymer (Histofine
Simple Stain MAX-PO (Rat); Nichirei Biosciences, Tokyo,
Japan) at room temperature for 30 minutes. The sections
for MMP-13 were incubated with polyclonal rabbit anti-
sheep immunoglobulins, which were conjugated with
horseradish peroxidase, diluted 1:100 (Dako, Glostrup,
Denmark) at room temperature for 30 minutes. The bound
antibodies were visualized with 3,30-diaminobenzine con-
taining 0.003% H2O2. The negative control was confirmed by
incubation without primary or secondary antibody to show
no positive cells. The sections were washed with PBS (pH
7.4) three times after each incubation, except before
addition of the primary antibodies. All sections were
counterstained with Mayer’s hematoxylin at room temper-
ature for 3 minutes before mounting with glycergel
mounting medium (MOUNT-QUICK; Daido Sangyo, Saitama,
Japan).
Double immunofluorescence
Immunohistochemical analysis was performed using the
same 4-mm sections. All sections were deparaffinized in
xylene, followed by 100% ethanol. Thereafter, microwave
antigen retrieval was performed with hot 0.01 mol/L-
citrate buffer for 10 minutes. The sections were then
blocked with blocking solution for 30 minutes. They were
reacted with anti-mouse F4/80 diluted 1:200 (Serotec,
Raleigh, NC, USA), which is a marker of macrophages.
After overnight incubation at 4C, the sections were
washed in PBS three times to stop the reaction, followed
by reaction with tetramethyl rhodamine isothiocyanate as
secondary antibody at room temperature for 40 minutes.
The sections were washed with PBS. They were reacted
with anti-MMP13 diluted 1:20 (Anaspec), which reacted
with MMP-13. After an overnight incubation at 4C, the
sections were washed with PBS and mounted in diluted
@@@FITC as secondary antibody at room temperature for
40 minutes.
Results
Morphologic changes of the anterior parietal
peritoneum
In control mice, peritoneal tissues consisted of a meso-
thelial monolayer and thin connective tissues under
the mesothelial layer (Fig. 1A). On day 21, repeated
CG stimulation induced edematous thickening of the
peritoneum, marked mononuclear cell infiltration, and
Figure 1 Morphological findings in anterior parietal peritoneum. (A) Mesothelial monolayer and thin submesothelial compact
zone (SMC) were observed in control mesothelium. (B and C) Edematous thickened mesothelium with many infiltrating mesothelial
cells and angiogenesis was found on days 21 and 28. (DeF) Thickness of SMC and number of infiltrating mononuclear cells were
decreased on days 35, 42, and 49. (E and F) Mesothelial monolayer on the peritoneal surface and many spindle-shaped cells in SMC
were found on days 42 and 49. (G) Thin SMC was observed on day 56. 100. bed. 400. Masson’s trichrome staining.
10 S. Aruga et al.angiogenesis (Fig. 1B). On day 28, marked mononuclear
cell infiltration and thickening of the SMC remained
(Fig. 1C). On day 35, cell infiltration and thickness of the
peritoneum were decreased (Fig. 1D). On day 42, marked
regression of SMC thickening and cell infiltration were
observed (Fig. 1E). A mesothelial monolayer was found onthe peritoneal surface (Fig. 1E). Thickening of SMC induced
by CG was gradually decreased after cessation of CG
(control, 2.67 0.85 mm; day 21, 199.73 36.21 mm; day
28, 197.08 26.71 mm; day 35, 152.13 24.35 mm; day 42,
133.5 31.88 mm; day 49, 87.86 20.07 mm; day 56,
32.47 6.60 mm).
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Messenger RNAs isolated from parietal peritoneal tissues at
days 21, 28, 35, 42, 49, and 56 were analyzed by real-time
PCR. CG enhanced expressions of collagen type I and type
III, MMP-13 and -2, TIMP-1 and -2, and TGF-b1 mRNAs in the
parietal peritoneum (Fig. 2AeG). Levels of TGF-b1,
collagen type I, and type III mRNA were elevated until day
28 (Fig. 2A,B and G). These levels then gradually decreased
in the following weeks (Fig. 2A,B and G). However, the
highest level of MMP-13 mRNA was at day 21, and thenFigure 2 Serial expressions of mRNA in anterior parietal periton
filled boxes, after cessation of CG. (A) Collagen type I, a: p< 0.05 v
d: p< 0.01 vs. on day 21, e: p< 0.001 vs. on day 28. (B) Collagen typ
vs. on day 21, d: p< 0.05 vs. on day 28, e: p< 0.0001 vs. on day 28. (
c: p< 0.01 vs. on day 28. (D) MMP-2, a: p< 0.002 vs. control. b: p
p< 0.01 vs. control. b: p< 0.01 vs. on day 28, c: p< 0.001 vs. on d
21, c: p< 0.01 vs. on day 28. (G) TGF-b1, a: p< 0.01 vs. control. brapidly decreased in the following weeks (Fig. 2C). Levels of
MMP-2 and TIMP-1 and-2 mRNA were elevated until day 28,
and then gradually decreased following the observation
period (Fig. 2D,E and F).MMP-13 enzyme activity
Levels of MMP-13 activity increased compared with those in
the control on day 21, and then rapidly decreased following
the observation period (Fig. 3).eum. Blank boxes, control; dotted boxes, at cessation of CG;
s. control. b: p< 0.0001 vs. control, c: p< 0.002 vs. on day 21,
e III, a: p< 0.05 vs. control. b: p< 0.001 vs. control, c: p< 0.02
C) MMP-13, a: p< 0.002 vs. control. b: p< 0.0001 vs. on day 21,
< 0.02 vs. on day 21, c: p< 0.02 vs. on day 28. (E) TIMP-1, a:
ay 28. (F) TIMP-2, a: p< 0.05 vs. control. b: p< 0.01 vs. on day
: p< 0.01 vs. on day 21, c: p< 0.01 vs. on day 28.
Figure 2 (continued).
Figure 3 MMP-13 activity.
12 S. Aruga et al.Immunohistochemical analysis of the peritoneum
Many macrophages (i.e., F4/80-expressing cells) were
found in the whole thickness of the SMC on day 21 (Fig. 4A).
Infiltrating macrophages in SMC were decreased on days
28 and 35 (Fig. 4B and C). Many round-shaped MMP-13
expressing cells were observed in the whole SMC on day 21
(Fig. 4D). On days 28 and 35, some MMP-13 expressing cells
were found in SMC (Fig. 4E and F). Most MMP-13 expressing
cells appeared round-shaped on day 21 (Fig. 4G). Spindle-
and round-shaped MMP-13 cells were found simultaneously
on days 28 and 35 (Fig. 4H and I). On day 21, some
macrophages in SMC expressed MMP-13 (Fig. 5).
Discussion
Characteristics of morphological alterations in long-term PD
patients include the marked thickening of the peritoneum
Figure 4 (A) Many macrophages, expressing F4/80 cells, spread over the whole thickened SMC on day 21. (B, D, and F) MMP-13
expressing cells also spread over the whole thickened SMC on days 21, 28, and 35. (C) Some macrophages were found in the whole
thickened SMC. (D) The number of infiltrating macrophages was decreased on day 28. (E) Some macrophages were found over the
whole thickened SMC on day 35. 200. (G) Many round-shaped infiltrating cells in the thickened SMC expressed MMP-13 on 21 day.
(H and I) Spindle-shaped MMP-13 expressing cells also spread over the whole thickened SMC on 28 and 35 days. Arrowheads show
MMP-13 positive cells. 1000.
Pattern of MMPs and TGF-b1 during repair in PF mice 13and vasculopathy in the SMC.1 It is still unclear whether
severely injured peritoneum is associated with long-term
PD repair. Recovery from PF was involved in the destruc-
tion of fibrosis in the peritoneum. In such events, MMPs and
TIMPs are thought to play important roles in biological
processes that involve angiogenesis, tissue remodeling, and
tissue degeneration under physiological and pathological
conditions.15,16 We showed differential expression levels
over time of the various gene products that are involved in
tissue repair in the PF mouse. The spatial and temporal
induction of different key players is linked to the role of
these gene products in the healing process. Since alter-
ations of the peritoneal membrane are similar in CG-
induced PF animals and in long-term PD patients, weutilized CG-induced PF mice in this study. The common
histological findings include increased accumulation of
interstitial collagens such as collagen types I and III, infil-
tration of monocytes/macrophages, and increase in a-SMA-
positive myofibroblasts and vascular density in the
peritoneum.17,18
In this study, synthesis of collagen types I and III
increased after cessation of CG and peaked at day 7. In
response to collagen synthesis, the SMC on day 28 was
thicker than that on day 21. Therefore, cessation of stim-
ulant does not result in a switch from PF to repair imme-
diately. Ulrich et al3 reported that fibrosis-specific type of
cross-linking of collagens, MMPs and TGF-b1, seen in human
scars, plays a harmonic role in the healing process.
Figure 4 (continued).
Figure 5 Fluorescent immunostaining of infiltrating cells in
SMC on 21 day. (A) Many MMP-13 expressing cells were found in
SMC. 1000. (B) Many macrophages and F4/80 positive cells
were also observed. 1000. (C) Some macrophages coex-
pressed MMP-13 (arrowheads). 1000.
14 S. Aruga et al.Evaluated TGF-b1 synthesis reached a peak not at cessation
of CG, but after 7 days. Synthesis of MMP-2, MT1-MMP, and
TIMP-1 and -2 increased until 7 days after cessation of CG,
and then rapidly decreased.
MMP-13 synthesis peaked at cessation before these
increments. MMP-13 mainly cleaves fibrillar collagen types
Pattern of MMPs and TGF-b1 during repair in PF mice 15I, II, and III into characteristic 3/4 and 1/4 fragments.6
However, the degradation activity of MMP-13 is weaker
than that of gelatinase A.19 Biochemical characterization of
recombinant human MMP-13 has shown that this enzyme
cleaves type II collagen about 6-fold more effectively than
types I and III collagens, and displays a 40-fold stronger
gelatinase activity than those of the collagenases.19 MMP-
13 is expressed when either rapid or effective remodel-
ing20 or excessive degradation of collagenous extracellular
matrices takes place.21 In human wounds, MMP-13 expres-
sion is reported to occur only in connective tissues of
chronic wounds.22 Wu et al23 suggested that MMP-13
expression was biphasic, with peak activities at days 15
and 37 after injury in free-electron laser and scalpel inci-
sions. They noted that early expression of MMP-13 by
fibroblasts contributed to re-epithelialization, and late
expression was involved in long-term collagen remodeling
and skeletal muscle repair.23 Hattori et al24 also reported
that MMP-13 plays a role in keratinocyte migration, angio-
genesis, and contraction in mouse skin wound healing. In
this study, peak levels of MMP-13 synthesis and activity
were observed at cessation of CG and then decreased
immediately. In spatial assessment, the expressing cells
were observed in the whole thickened parietal peritoneum
in this study. The level of MMP-13 expression at day 21
significantly increased compared with that during CG
stimulation (data not shown). Therefore, MMP-13 may
contribute not only to re-epithelialization, and late
expression was involved in long-term collagen remodeling
in the CG-induced PF mouse.
The degradation activity of collagen types I and III for
MMP-13 was higher than that of the gelatinases.19 However,
once collagen fragments are cleaved by collagenases, the
fragments are effectively digested by MMP-2 and -9.25
Improvement of the thickened SMC was found to
contribute to amplification of gelatinase synthesis in this
study. Gelatinases, such as MMP-2 and MMP-9, also
degraded components of collagen type IV and fibronectin,
which comprise the basement membrane, and play impor-
tant roles in angiogenesis and cell migration.26,27 Once TGF-
b1 is activated, it stimulates the synthesis of collagens and
increases MMP-2 activity through suppression of TIMP-2.
Additionally, TGF-b1 suppresses MMP-13 activity via inhibi-
tion of synthesis and activation of TIMP-1.11,12 Therefore,
synthesis of MMP-13 might be rapidly decreased since TGF-
b1 synthesis was increased in this study. MMP13 also has
a central position in the MMP activation cascade, both
activating and being activated by several MMPs.19 Meso-
thelial monolayer was observed at day 14 after cessation of
CG in this study, and then peritoneal repair was accelerated
(data not shown). Therefore, it appears that clearance of
fragmented collagen by increased MMP-2 facilitates
reconstruction of tissue destroyed during peritoneal repair.
Fallowfield et al28 suggested scar-associated macro-
phages are a major source of hepatic MMP-13 and facilitate
the resolution of murine hepatic fibrosis. Macrophages are
recognized as a major source of MMPs.28 Macrophages can
influence matrix turnover both directly by producing
MMPs29 and indirectly by secretion of cytokines including IL-
1 and TNF-a that modulate MMP production by other resi-
dent cell types.30 We propose that macrophages represent
the primary source of MMP13 in relevant models of PF.In this study, some infiltrating macrophages in the
thickened peritoneum induced and used MMP-13 to mediate
the resorption of interstitial matrix through interaction
with other MMPs and cytokines in peritoneal remodeling. It
appears that MMP-13 might play a prominent role in PF and
may be a key player in peritoneal remodeling after cessa-
tion of stimuli.References
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